IQM Quantum Computers has bolstered its executive team with two key appointments ahead of its planned public listing on the Nasdaq. The company named Dr. Craig Ciesla as its new Chief Technology Officer and promoted Dr. Inés de Vega to Chief Scientist. These strategic hires are set to deepen IQM's technological leadership as it prepares to merge with Real Asset Acquisition Corp.
Strengthening Technical Leadership
As the new Chief Technology Officer, Dr. Craig Ciesla will spearhead IQM's technology strategy and oversee its implementation into commercial systems. His primary focus will be on scaling the company's complex instrumentation platforms and building a world-class research and development organization. This role is critical as IQM accelerates its path toward fault-tolerant quantum computing.
Dr. Inés de Vega, in her new capacity as Chief Scientist, will ensure scientific feasibility and system-level consistency across all of IQM's technology. Transitioning from her previous role as Vice President of Quantum Solutions, she will continue to shape the company's long-term technology roadmap. Her deep expertise will be vital for maintaining the scientific integrity of IQM's products.
A Wealth of Industry Experience
Dr. Ciesla brings over 25 years of experience in deep tech, holding previous leadership positions at prominent companies like 10x Genomics, Illumina, and Intel. He is a proven innovator and product development leader, credited as an inventor on more than 100 patents and patent applications. His extensive background includes significant board experience, complementing his PhD in Physics.
Dr. de Vega possesses more than two decades of experience advancing quantum technologies from fundamental research to industrial applications. Her distinguished career includes research roles at prestigious institutions such as the Max Planck Institute of Quantum Optics and the University of Ulm. She has been instrumental in developing quantum algorithms and advanced error-correction tools.
A Strategic Vision for Growth
Jan Goetz, CEO and Co-founder of IQM, expressed confidence in the new appointments and their potential impact on the company's future. "Ciesla's track record of scaling complex platforms makes him an exceptional addition to our leadership team," Goetz stated. He also thanked Dr. de Vega for her outstanding contributions and her continued role in shaping their technology.
The new appointees shared their enthusiasm for IQM's mission and its market position. Dr. Ciesla noted he was attracted to the company's commitment to building production-grade quantum systems that customers can operate today. Dr. de Vega expressed her excitement to further contribute to the company's impressive growth trajectory.
Paving the Way for Public Listing
These leadership changes occur as IQM continues to solidify its position as a global leader in superconducting quantum computers. The company operates as a fully vertically integrated entity with its own chip factory and has sold 23 quantum computers to date. This operational control and market penetration distinguish IQM from its competitors.
The appointments are timed strategically as IQM nears its Nasdaq listing through a merger with Real Asset Acquisition Corp. The transaction has gained significant momentum, recently securing an upsized PIPE investment of $146 million. This financial backing underscores strong investor confidence in IQM's strategy and future prospects.
The appointments of Dr. Ciesla and Dr. de Vega mark a significant milestone for IQM Quantum Computers. By strengthening its technical and scientific leadership, the company is strategically positioning itself for a successful transition to the public market. This move reinforces IQM's commitment to innovation and its readiness for the next phase of commercial expansion.